Trial site
Sarah Cannon Research Institute - Oncology Partners
- 11running trials
- 2closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Colorectal cancer4 trials
- Liver and biliary tract cancer3 trials
- Melanoma3 trials
- Pancreatic cancer3 trials
- Prostate cancer3 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Endometrial cancer1 trial
- Kidney cancer1 trial
- Neuroendocrine tumours1 trial
- Sarcoma1 trial
- and 1 more
- Phase
- Phase 17 trials
- Phase 1/24 trials
- Phase 22 trials
- Phase 31 trial
- Status
- Recruiting9 trials
- Active, not recruiting2 trials
- Completed1 trial
- Suspended1 trial
- Withdrawn1 trial
- Lead sponsor
- Amgen4 trials
- SystImmune Inc.2 trials
- Aminex Therapeutics, Inc.1 trial
- IDEAYA Biosciences1 trial
- NextPoint Therapeutics, Inc.1 trial
- and 5 more
Running trials
Recruiting
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Recruiting
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Recruiting
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Recruiting
Recruiting
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Recruiting
Active, not recruiting
Active, not recruiting
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Colorectal cancer3 recruiting
- Melanoma3 recruiting
- Prostate cancer2 recruiting
- Neuroendocrine tumours1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Recruiting
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026